pharma · Peripheral Artery Disease · Muscle-Invasive Bladder Carcinoma
Blackmores Institute
Blackmores Limited
Blackmores Institute clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 20 Jubilee Ave, Warriewood, New South Wales 2102, AU
- Founded
- 2012
- Employees
- 27
- Programs
- 17
- Drugs
- 24
- Patents
- 38
Blackmores Institute projects
6 ClinicalTrials.gov programs sponsored by Blackmores Institute.
Blackmores Institute has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Azathioprine 50Mg Tab
Blackmores Limited
Therapeutic Equivalency
1 trial -
BDTX-189
Blackmores Limited
Solid Tumor
1 trial -
Levodopa
Blackmores Limited
Parkinson's Disease
1 trial -
Liberase Enzyme (Roche)
Blackmores Limited
Pulmonary Alveolar Proteinosis
1 trial -
Normal Saline (NS) .9% 10 mL Injection
Blackmores Limited
Ovarian Failure
1 trial -
YF476
Blackmores Limited
Hypergastrinaemia
2 trials
Frequently asked questions
How many clinical projects does Blackmores Institute have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.